Baxter International Inc

詳細情報 Baxter International Inc 企業名

Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.

企業情報

企業コードBAX

会社名Baxter International Inc

上場日May 15, 1961

設立日1931

最高経営責任者「CEO」Mr. D. Brent Shafer

従業員数38000

証券種類Ordinary Share

決算期末May 15

本社所在地One Baxter Parkway

都市DEERFIELD

証券取引所NYSE Consolidated

国United States of America

郵便番号60015

電話番号12249482000

ウェブサイトhttps://www.baxter.com/

企業コードBAX

上場日May 15, 1961

設立日1931

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Heather Knight

Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies

177.32K

+11.79%

Dr. Jeanne K. Mason, Ph.D.

Chief Human Resources Officer, Executive Vice President

141.67K

+7.47%

Mr. Alok Sonig

Executive Vice President, Group President - Pharmaceuticals

130.30K

+15.20%

Mr. David S. Rosenbloom

Executive Vice President, General Counsel

101.60K

-14.01%

Dr. Stephen N. (Steve) Oesterle, M.D.

Independent Director

35.70K

+25.18%

Ms. Catherine R. (Cathy) Smith

Independent Director

30.23K

+31.17%

Ms. Patricia B. Morrison

Independent Director

22.94K

+45.58%

Mr. Stephen H. (Steve) Rusckowski

Independent Director

16.45K

+77.49%

Mr. Jeffrey A. (Jay) Craig

Independent Director

10.65K

+206.88%

Ms. Nancy M. Schlichting

Lead Independent Director

7.97K

+912.71%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Heather Knight

Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies

177.32K

+11.79%

Dr. Jeanne K. Mason, Ph.D.

Chief Human Resources Officer, Executive Vice President

141.67K

+7.47%

Mr. Alok Sonig

Executive Vice President, Group President - Pharmaceuticals

130.30K

+15.20%

Mr. David S. Rosenbloom

Executive Vice President, General Counsel

101.60K

-14.01%

Dr. Stephen N. (Steve) Oesterle, M.D.

Independent Director

35.70K

+25.18%

Ms. Catherine R. (Cathy) Smith

Independent Director

30.23K

+31.17%

収益内訳

通貨: USD更新時刻: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

事業別USD

会社名

収益

比率

Infusion Therapies and Technologies

4.10B

38.58%

Care and Connectivity Solutions

1.81B

17.06%

Injectables and Anesthesia

1.37B

12.91%

Front Line Care

1.14B

10.69%

Advanced Surgery

1.10B

10.38%

Other

1.10B

10.39%

地域別USD

会社名

収益

比率

United States

5.85B

55.00%

International

4.79B

45.00%

事業別

地域別

事業別USD

会社名

収益

比率

Infusion Therapies and Technologies

4.10B

38.58%

Care and Connectivity Solutions

1.81B

17.06%

Injectables and Anesthesia

1.37B

12.91%

Front Line Care

1.14B

10.69%

Advanced Surgery

1.10B

10.38%

Other

1.10B

10.39%

株主

更新時刻: Thu, May 1

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

11.85%

Dodge & Cox

10.03%

Pzena Investment Management, LLC

7.17%

BlackRock Institutional Trust Company, N.A.

5.90%

State Street Global Advisors (US)

4.24%

Other

60.81%

株主統計

比率

The Vanguard Group, Inc.

11.85%

Dodge & Cox

10.03%

Pzena Investment Management, LLC

7.17%

BlackRock Institutional Trust Company, N.A.

5.90%

State Street Global Advisors (US)

4.24%

Other

60.81%

種類

株主統計

比率

Investment Advisor/Hedge Fund

54.69%

Investment Advisor

32.69%

Hedge Fund

2.91%

Research Firm

2.31%

Pension Fund

1.95%

Insurance Company

1.46%

Bank and Trust

1.26%

Sovereign Wealth Fund

0.98%

Individual Investor

0.37%

Other

1.38%

機関投資家保有株

更新時刻: Thu, Feb 20

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q1

1908

505.98M

98.60%

-40.93M

2024Q4

1984

501.11M

97.98%

-41.68M

2024Q3

2005

485.40M

95.14%

-42.32M

2024Q2

2042

472.72M

92.77%

-47.98M

2024Q1

2091

469.13M

92.11%

-57.76M

2023Q4

2137

471.69M

92.98%

-44.04M

2023Q3

2123

465.39M

91.91%

-35.52M

2023Q2

2140

458.55M

90.66%

-30.65M

2023Q1

2123

459.27M

90.86%

-22.24M

2022Q4

2132

456.58M

90.57%

-21.28M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

60.53M

11.8%

+468.84K

+0.78%

Dec 31, 2024

Dodge & Cox

51.58M

10.06%

+1.20M

+2.39%

Feb 28, 2025

Pzena Investment Management, LLC

33.64M

6.56%

+1.42M

+4.39%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

29.53M

5.76%

-652.43K

-2.16%

Dec 31, 2024

State Street Global Advisors (US)

21.79M

4.25%

+12.21K

+0.06%

Dec 31, 2024

T. Rowe Price Associates, Inc.

15.25M

2.97%

+1.13M

+8.03%

Dec 31, 2024

BlackRock Financial Management, Inc.

17.57M

3.43%

+1.23M

+7.54%

Dec 31, 2024

Geode Capital Management, L.L.C.

12.45M

2.43%

+290.28K

+2.39%

Dec 31, 2024

Harris Associates L.P.

8.46M

1.65%

-1.31M

-13.43%

Dec 31, 2024

Columbia Threadneedle Investments (US)

7.28M

1.42%

-2.29M

-23.93%

Dec 31, 2024

詳細を見る

関連ETF

更新時刻: Fri, Jun 6

銘柄名

比率

Parnassus Value Select ETF

3.74%

Cullen Enhanced Equity Income ETF

2.96%

iShares Large Cap Value Active ETF

2.85%

First Trust Indxx Medical Devices ETF

2.02%

North Shore Equity Rotation ETF

1.94%

iShares U.S. Medical Devices ETF

1.88%

Global X S&P 500 Quality Dividend ETF

1.88%

SPDR S&P Health Care Equipment ETF

1.58%

Invesco S&P 500 Equal Weight Health Care ETF

1.5%

ROBO Global Healthcare Technology & Innovation ETF

1.02%

詳細を見る

Parnassus Value Select ETF

比率3.74%

Cullen Enhanced Equity Income ETF

比率2.96%

iShares Large Cap Value Active ETF

比率2.85%

First Trust Indxx Medical Devices ETF

比率2.02%

North Shore Equity Rotation ETF

比率1.94%

iShares U.S. Medical Devices ETF

比率1.88%

Global X S&P 500 Quality Dividend ETF

比率1.88%

SPDR S&P Health Care Equipment ETF

比率1.58%

Invesco S&P 500 Equal Weight Health Care ETF

比率1.5%

ROBO Global Healthcare Technology & Innovation ETF

比率1.02%

配当金

過去5年間の配当金総支払額は 2.75B 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

Feb 11, 2025

BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 01, 2025 going ex on Feb 28, 2025 with reinvestment option

Feb 28, 2025

Apr 01, 2025

Feb 28, 2025

Nov 11, 2024

BAX.NB Final Cash Dividend of gross USD 0.17 paid on Jan 02, 2025 going ex on Nov 29, 2024 with reinvestment option

Nov 29, 2024

Jan 02, 2025

Nov 29, 2024

Jul 16, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 01, 2024 going ex on Aug 30, 2024 with reinvestment option

Aug 30, 2024

Oct 01, 2024

Aug 30, 2024

May 07, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 01, 2024 going ex on May 31, 2024 with reinvestment option

May 31, 2024

Jul 01, 2024

May 31, 2024

Feb 12, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 01, 2024 going ex on Feb 29, 2024 with reinvestment option

Mar 01, 2024

Apr 01, 2024

Feb 29, 2024

Nov 14, 2023

BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 02, 2024 going ex on Nov 30, 2023 with reinvestment option

Dec 01, 2023

Jan 02, 2024

Nov 30, 2023

Jul 18, 2023

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 02, 2023 going ex on Aug 31, 2023 with reinvestment option

Sep 01, 2023

Oct 02, 2023

Aug 31, 2023

May 01, 2023

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 03, 2023 going ex on Jun 01, 2023

Jun 02, 2023

Jul 03, 2023

Jun 01, 2023

Feb 14, 2023

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 03, 2023 going ex on Feb 23, 2023 with reinvestment option

Feb 24, 2023

Apr 03, 2023

Feb 23, 2023

Nov 15, 2022

BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 03, 2023 going ex on Dec 01, 2022

Dec 02, 2022

Jan 03, 2023

Dec 01, 2022

詳細を見る

株式分割

日付

種類

比率

データなし

日付

種類

比率

データなし

30.610USD

Baxter International Inc

30.610

概要

企業名